CV Sciences (CVSI) Enterprise Value (2011 - 2026)
CV Sciences (CVSI) reported Enterprise Value of -$309000.0 for Q1 2026, up 61.95% on a YoY basis from -$190804.6 in Q1 2025, and down 11.15% sequentially from -$278000.0 in Q4 2025.
CV Sciences (CVSI) Enterprise Value (2011 - 2026) Analysis & Trends
CV Sciences (CVSI) has 16 years of Enterprise Value data on file, last reported at -$309000.0 in Q1 2026.
- For the quarter ending Q1 2026, Enterprise Value rose 61.95% year-over-year to -$309000.0; the trailing twelve-month figure through Mar 2026 stood at -$309000.0 (up 61.95% YoY), and the FY2025 full-year result was -$278000.0, up 38.77% from the prior year.
- Enterprise Value retreated to -$309000.0 in Q1 2026, from -$278000.0 in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$278000.0 in Q4 2025 to a low of -$2.4 million in Q1 2022.
- A 5-year average of -$935588.2 and a median of -$812000.0 in 2025 frame the typical range for Enterprise Value.
- Across the five-year window, Enterprise Value sank 115.55% in 2023 and soared 71.78% in 2024, its largest moves.
- Tracing CVSI's Enterprise Value over 5 years: stood at -$611000.0 in 2022, then slumped by 115.55% to -$1.3 million in 2023, then jumped by 65.53% to -$454000.0 in 2024, then soared by 38.77% to -$278000.0 in 2025, then decreased by 11.15% to -$309000.0 in 2026.
- Business Quant data shows CVSI's Enterprise Value at -$309000.0 in Q1 2026, -$278000.0 in Q4 2025, and -$381000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | -1.86 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -3.74 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | -1.94 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -4.05 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -2.15 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | -33.59 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -1.80 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | -1.32 Bn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -428.00 Mn |
| 10 | CV Sciences | 3.74 Mn | 3.43 Mn | 1.56 Mn | -309,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -309,000.00 |
| Dec 31, 2025 | -278,000.00 |
| Sep 30, 2025 | -381,000.00 |
| Jun 30, 2025 | -886,000.00 |
| Mar 31, 2025 | -812,000.00 |
| Dec 31, 2024 | -454,000.00 |
| Sep 30, 2024 | -979,000.00 |
| Jun 30, 2024 | -477,000.00 |
| Mar 31, 2024 | -662,000.00 |
| Dec 31, 2023 | -1.32 Mn |
| Sep 30, 2023 | -1.64 Mn |
| Jun 30, 2023 | -1.69 Mn |
| Mar 31, 2023 | -714,000.00 |
| Dec 31, 2022 | -611,000.00 |
| Sep 30, 2022 | -1.14 Mn |
| Jun 30, 2022 | -1.11 Mn |
| Mar 31, 2022 | -2.44 Mn |
| Dec 31, 2021 | -1.38 Mn |
| Jun 30, 2021 | -2.96 Mn |
| Mar 31, 2021 | -5.67 Mn |